---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-008344"
form_type: "8-K"
ticker: "JUNS"
cik: "0001679628"
company_name: "JUPITER NEUROSCIENCES, INC."
filed_at: "2026-02-27T23:59:59+00:00"
generated_at: "2026-05-15T23:06:05.492294+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Jupiter Neurosciences receives Nasdaq deficiency notices for bid price and market value

## Summary
- Two Nasdaq deficiency notices received Feb 26, 2026: bid price <$1.00 for 30 consecutive days.
- Market value of listed securities (MVLS) <$35M for 30 consecutive days; both have 180-day cure period to Aug 25, 2026.
- To regain bid price compliance, stock must close ≥$1.00 for 10+ consecutive business days.
- Company may consider reverse stock split; trading unaffected for now under ticker JUNS.
- Failure to cure may lead to delisting; Company can appeal to a hearings panel.

## SEC filing metadata
- accession: 0001493152-26-008344
- form_type: 8-K
- ticker: JUNS
- cik: 0001679628
- company_name: JUPITER NEUROSCIENCES, INC.
- filed_at: 2026-02-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1679628/000149315226008344/0001493152-26-008344-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1679628/000149315226008344/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-008344
- JSON: https://secwatch.observer/filing/0001493152-26-008344.json
- Plain text: https://secwatch.observer/filing/0001493152-26-008344.txt

## Source-grounded claims
- claim_id: 504545a4a4d590ff34f45f34f73d7386e0984e15
  claim: JUPITER NEUROSCIENCES, INC. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).
  evidence_excerpt: February 26, 2026, Jupiter Neurosciences, Inc. (the “ Company ”) received two written notices (each, a “ Notice ” and together, the “ Notices ”) from the Listing Qualifications Department of Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that (i) the listing of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”) was not in compliance with the minimum bid price requirement (the “ Minimum Bid Price Requirement ”) as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing of its Common Stock on The Nasdaq Capital Market, as the closing bid price
  evidence_url: https://www.sec.gov/Archives/edgar/data/1679628/000149315226008344/0001493152-26-008344-index.htm
- claim_id: c0a7d8d9bc1eb5a5d2c672112bab1fc958801263
  claim: JUPITER NEUROSCIENCES, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  evidence_excerpt: February 26, 2026, Jupiter Neurosciences, Inc. (the “ Company ”) received two written notices (each, a “ Notice ” and together, the “ Notices ”) from the Listing Qualifications Department of Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that (i) the listing of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”) was not in compliance with the minimum bid price requirement (the “ Minimum Bid Price Requirement ”) as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing of its Common Stock on The Nasdaq Capital Market, as the closing bid price
  evidence_url: https://www.sec.gov/Archives/edgar/data/1679628/000149315226008344/0001493152-26-008344-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.